Tagged: 'Roche'

It's that time of the year when big pharmaceutical companies like to buy up the smaller biopharmceutical businesses that are developing treatments and therapies.

Roche

Poseida Therapeutics

TG Therapeutics may be a takeover target for Roche, tweets ex Times business hack Dom Walsh

Wednesday, 13 November 2024 4:46 pm

Dominic "Dom" Walsh is at it again.

Roche in talks to buy Roivant Sciences drug for $7 billion, reveals The Wall Street Journal

Friday, 14 July 2023 9:37 amHacks at The Wall Street Journal landed a decent scoop overnight about Switzerland's Roche talks to buy a stomach drug from Roivant Sciences, the US-listed biotechnology group.

Back on Tip TV talking about Henderson Group, Molson Coors and Illumina

Monday, 03 October 2016 1:48 pmI have pasted a link to today's Tip TV session below for avid followers who failed to tune in for this morning's banter.

betaville

Roche

Molson Coors Brewing Company

Illumina

Henderson Group

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Thursday, 21 July 2016 9:46 pmAccording to the Bloomberg story I read, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are too high. Dr Schwan, though, refused to comment when the Bloomberg hack tried to elicit a denial or confirmation by asking him spefically about Roche's interest in BioMarin.

Bloomberg

BioMarin

Roche

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Wednesday, 06 July 2016 12:00 amRoche is said to be once again exploring a multi-billion takeover bid for US rare disease specialist BioMarin

Deals, deals, deals ... in a bear market - Part 85

Thursday, 07 May 2026 3:17 pm

A fresh bunch of deals were announced this morning amid the current stock market melt up.

Roche

Catalyst Pharmaceuticals

Path AI

Swedish Orphan Biovitrum AB

Angelini Pharma S.p.A

Roche snaps up 89bio Inc for $3.5 billion

Thursday, 18 September 2025 8:46 am

Swiss pharmaceutical giant Roche has opted to purchase US-listed 89bio Inc for $3.5 billion.

Roche

89bio

Roche Holdings snaps up Poseida Therapeutics for up to $1.5 billion

Tuesday, 26 November 2024 8:29 am

It's that time of the year when big pharmaceutical companies like to buy up the smaller biopharmceutical businesses that are developing treatments and therapies.

Roche

Poseida Therapeutics

TG Therapeutics may be a takeover target for Roche, tweets ex Times business hack Dom Walsh

Wednesday, 13 November 2024 4:46 pm

Dominic "Dom" Walsh is at it again.

Roche in talks to buy Roivant Sciences drug for $7 billion, reveals The Wall Street Journal

Back on Tip TV talking about Henderson Group, Molson Coors and Illumina

Monday, 03 October 2016 1:48 pmI have pasted a link to today's Tip TV session below for avid followers who failed to tune in for this morning's banter.

betaville

Roche

Molson Coors Brewing Company

Illumina

Henderson Group

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Bloomberg

BioMarin

Roche

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Wednesday, 06 July 2016 12:00 amRoche is said to be once again exploring a multi-billion takeover bid for US rare disease specialist BioMarin

Subscriptions

Independent Editorial

Tagged: 'Roche'

Deals, deals, deals ... in a bear market - Part 85

Roche snaps up 89bio Inc for $3.5 billion

Roche Holdings snaps up Poseida Therapeutics for up to $1.5 billion

TG Therapeutics may be a takeover target for Roche, tweets ex Times business hack Dom Walsh

Roche in talks to buy Roivant Sciences drug for $7 billion, reveals The Wall Street Journal

Back on Tip TV talking about Henderson Group, Molson Coors and Illumina

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Deals, deals, deals ... in a bear market - Part 85

Roche snaps up 89bio Inc for $3.5 billion

Roche Holdings snaps up Poseida Therapeutics for up to $1.5 billion

TG Therapeutics may be a takeover target for Roche, tweets ex Times business hack Dom Walsh

Roche in talks to buy Roivant Sciences drug for $7 billion, reveals The Wall Street Journal

Back on Tip TV talking about Henderson Group, Molson Coors and Illumina

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources